Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Sleep Apnea Syndrome or Atrial Fibrillation
and you are
between 18 and 79
years old
-
The phase for this study is not defined.
Show me locations

The purpose

The main aim of this project is to assess the effect of Sleep apnea syndrome (SAS) screening (and treatment if SAS is moderate to severe, defined by an apnea hypopnea index >15 / h) on recurrence of atrial fibrillation (AF) over a twenty-four month follow-up period, in patients on optimal medical treatment after AF ablation.

Provided treatments

  • Other: Intervention group
Wondering what is the locations section for?
We will connect you to the doctor responsible for this trial and help you get more information.

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02906839. The sponsor of the trial is Assistance Publique - Hôpitaux de Paris and it is looking for 280 volunteers for the current phase.
Official trial title:
Effect of Sleep Apnea Screening and Treatment on Atrial Fibrillation Recurrence : a Randomized Controlled Trial